Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Relapsed Small Cell Lung Cancer (SCLC)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT02876510
What this trial is testing

ACTolog in Patients With Solid Cancers

Who this might be right for
CancerSolid Tumor
Immatics US, Inc. 38
Not applicableStudy completedNCT01138358
What this trial is testing

Study of Episodic Breathlessness in Patients With Lung Cancer or Other Advanced Disease

Who this might be right for
DyspneaLung CancerMetastatic Cancer
King's College Hospital NHS Trust 50
Testing effectiveness (Phase 2)Study completedNCT02701400
What this trial is testing

Tremelimumab and Durvalumab With or Without Radiation Therapy in Patients With Relapsed Small Cell Lung Cancer

Who this might be right for
Recurrent Small Cell Lung Carcinoma
Emory University 18
Testing effectiveness (Phase 2)Ended earlyNCT00315211
What this trial is testing

Weekly Topotecan With Docetaxel in Recurrent Small Cell Lung Cancer

Who this might be right for
Mediastinal Neoplasms
Aultman Health Foundation 7
Testing effectiveness (Phase 2)Study completedNCT04993677
What this trial is testing

SEA-CD40 Given With Other Drugs in Cancers

Who this might be right for
MelanomaCarcinoma, Non-Small- Cell Lung
Seagen Inc. 77
Testing effectiveness (Phase 2)Study completedNCT00098254
What this trial is testing

BAY 43-9006 (Sorafenib) to Treat Relapsed Non-Small Cell Lung Cancer

Who this might be right for
Non-Small-Cell Lung Carcinoma
National Cancer Institute (NCI) 37
Testing effectiveness (Phase 2)Ended earlyNCT02351505
What this trial is testing

Selinexor in Treating Patients With Relapsed Small Cell Lung Cancer

Who this might be right for
Recurrent Small Cell Lung Carcinoma
Erin Bertino 1
Testing effectiveness (Phase 2)Study completedNCT00887159
What this trial is testing

Phase II Study of Cisplatin and Etoposide in Combination With Either Hedgehog Inhibitor GDC-0449 or IGF-1R MOAB IMC-A12 for Patients With Extensive Stage

Who this might be right for
Extensive Stage Small Cell Lung CarcinomaRecurrent Small Cell Lung Carcinoma
National Cancer Institute (NCI) 168
Testing effectiveness (Phase 2)Study completedNCT00005032
What this trial is testing

Bcl-2 Antisense Oligodeoxynucleotide G3139 and Paclitaxel in Treating Patients With Recurrent Small Cell Lung Cancer

Who this might be right for
Lung Cancer
University of Chicago 12
Testing effectiveness (Phase 2)Study completedNCT02769832
What this trial is testing

Nab-Paclitaxel With Gemcitabine for Relapsed Small Cell Cancer

Who this might be right for
Small Cell Lung Cancer (SCLC)
Muhammad Furqan 32
Large-scale testing (Phase 3)Looking for participantsNCT07189455
What this trial is testing

Study Comparing ZG006 With Investigator-Selected Chemotherapy in Participants With Relapsed Small Cell Lung Cancer

Who this might be right for
Small-cell Lung Cancer
Suzhou Zelgen Biopharmaceuticals Co.,Ltd 420
Early research (Phase 1)WithdrawnNCT00006126
What this trial is testing

Peripheral Stem Cell Transplantation in Treating Patients With Melanoma or Small Cell Lung, Breast, Testicular, or Kidney Cancer That is Metastatic or That Cannot Be Treated With Surgery

Who this might be right for
Breast CancerKidney CancerLung Cancer+2 more
Northwestern University
Early research (Phase 1)Study completedNCT00019825
What this trial is testing

Decitabine in Treating Patients With Unresectable Lung or Esophageal Cancer or Malignant Mesothelioma of the Pleura

Who this might be right for
Esophageal CancerLung CancerMalignant Mesothelioma+1 more
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05503888
What this trial is testing

Phase Ib/II Study of Almonertinib Combined With SHR-1701 in the Treatment of Relapsed or Advanced Non-small Cell Lung Cancer

Who this might be right for
Relapsed or Advanced Non-small Cell Lung Cancer
Suzhou Suncadia Biopharmaceuticals Co., Ltd. 160
Not applicableStudy completedNCT00900094
What this trial is testing

UMCC 003 Cancer-Related Protein Biomarkers in Blood and Tumor Tissue of Patients With Cancer

Who this might be right for
Breast CancerColorectal CancerEsophageal Cancer+4 more
University of Michigan Rogel Cancer Center 200
Not applicableStudy completedNCT00544336
What this trial is testing

Family Quality of Life Among Families With a Member Who is a Cancer Patient

Who this might be right for
Breast CancerColorectal CancerHead and Neck Cancer+3 more
Vanderbilt-Ingram Cancer Center 366
Large-scale testing (Phase 3)WithdrawnNCT03334487
What this trial is testing

Study Evaluating the Safety of Rovalpituzumab Tesirine for Third-Line and Later Treatment of Subjects With Relapsed or Refractory Small Cell Lung Cancer

Who this might be right for
Small Cell Lung Cancer
AbbVie
Testing effectiveness (Phase 2)Study completedNCT00062010
What this trial is testing

Interferon Alfa, Isotretinoin, and Paclitaxel in Treating Patients With Recurrent Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Eastern Cooperative Oncology Group 37
Early research (Phase 1)Study completedNCT00014066
What this trial is testing

Photodynamic Therapy Plus Brachytherapy in Treating Patients With Lung Cancer

Who this might be right for
Lung Cancer
Roswell Park Cancer Institute
Large-scale testing (Phase 3)Looking for participantsNCT06498479
What this trial is testing

ARTEMIS-008:HS-20093 Compared With Topotecan in Subjects With Relapsed Small Cell Lung Cancer

Who this might be right for
Small Cell Lung Cancer
Hansoh BioMedical R&D Company 460
Next Page